Companies whose shares are expected to trade actively in today’s session are Simcere Pharmaceutical Group (NYSE:SCR), Dicks Sporting Goods Inc (NYSE:DKS), Elan Corporation, plc (NYSE:ELN), Genworth Financial Inc (NYSE:GNW) and CYS Investments Inc (NYSE:CYS).
Simcere Pharmaceutical Group (NYSE:SCR): The Chinese drug maker’s chairman Jinsheng Ren, along with other investment firms, has offered to take the company private. Jinsheng Ren values Simcere at about $528 million, and finance the deal in all cash. Mr. Ren, Assure Ahead Investments Ltd and New Good Management Ltd. have offered $9.56 per American share, a 20 percent premium over its Friday close of $7.96. American shares of the company surged 13.69 percent to $9.05 in early trading.
Dicks Sporting Goods Inc (NYSE:DKS): The sporting-goods retailer’s fourth quarter earnings were lower than its own down estimates, and revenues fell short of analysts’ estimates. Dick’s also issued a pessimistic guidance for the current quarter and full year. Same-store sales dropped 2.2 percent in December quarter. Shares fell 8.04 percent to $46.53 in early market trading.
Elan Corporation, plc (NYSE:ELN): The Irish biotechnology firm said it will reward shareholders who remained invested in the company after the sale of its multiple sclerosis drug through a stock buyback program. Elan said it will pay 13 percent premium over its Friday’s closing price, or $13 per share to repurchase shares. American depository shares of the company surged 3.23 percent to $11.83 in the early session.
Genworth Financial Inc (NYSE:GNW): Analysts noted that the company’s growth is gaining momentum after the appointment of Thomas McInerney as CEO in January. Genworth shares are still trading at less than half of their book value. Additionally, a recovering mortgage market offers the company a solid opportunity to grow. Shares rose 7.01 percent to $10.53 in early trading.
CYS Investments Inc (NYSE:CYS): The real estate investment trust has lowered its quarterly dividend by 20 percent. CYS will pay only 32 cents per share in Q1 2013, down from 40 cents paid in the last quarter. Shares dipped 1.71 percent to $11.80 in early market trading.